RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Rafael Henkin(Queen Mary University of London), Catharien M. U. Hilkens(NIHR Newcastle Biomedical Research Centre), James Galloway(King's College London), Ian C. Scott(Midlands Partnership NHS Foundation Trust), Steve Young(Sandwell & West Birmingham Hospitals NHS Trust), Paul Emery(University of Leeds), Sarah Brockbank(Newcastle upon Tyne Hospitals NHS Foundation Trust), Faye A. H. Cooles(Newcastle upon Tyne Hospitals NHS Foundation Trust), Ayako Wakatsuki Pedersen(Newcastle upon Tyne Hospitals NHS Foundation Trust), Dennis Lendrem(Newcastle upon Tyne Hospitals NHS Foundation Trust), Fowzia Ibrahim(King's College London), Jessica Tarn(Newcastle upon Tyne Hospitals NHS Foundation Trust), Carl S. Goodyear(University of Glasgow), Heidi Lempp(King's College London), Tomi Lazarov(Memorial Sloan Kettering Cancer Center), Frédérique Ponchel(Mines Saint-Étienne), John Casement(Newcastle University), Jehan J. El‐Jawhari(University of Leeds), Aysın Tulunay Virlan(University of Glasgow), Ben Allen(Newcastle University), Gemma Molyneux(Institute of Cancer Research), Andrew Filer(Birmingham City University), David L. Scott(Oregon Health & Science University), Graham R. Smith(Newcastle University), Gemma Simpson(King's College London), Costantino Pitzalis(Queen Mary University of London), Iona Donnelly(Glasgow Royal Infirmary), Michael McDermott(Unknown), Duncan Porter(Gartnavel General Hospital), Karim Raza(University of Birmingham), David Watson(University of Iowa), Philip Jones(The University of Texas MD Anderson Cancer Center), Philip Stocks(Newcastle upon Tyne Hospitals NHS Foundation Trust), Iain B. McInnes(University of Glasgow), Ruth Toward(King's College London), Hayley Noble(King's College London), Rekha Parmar(University of Leeds), Amy E. Anderson(Newcastle University), Samana Schwank(King's College London), Frédéric Geissmann(Memorial Sloan Kettering Cancer Center), Julie Diboll(Newcastle upon Tyne Hospitals NHS Foundation Trust), Wing Cheung Vincent Wu(King's College London), Michael R. Barnes(Munich Cluster for Systems Neurology), Angela Parke(King's College London), Fiona Clarke(King's College London), Rachel A. Harry(Newcastle upon Tyne Hospitals NHS Foundation Trust), Benjamin A. Fisher(Birmingham City University), Ashley Gilmour(University of Glasgow), Andrew P. Cope(King's College London)
Cited by 25
Related Papers
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Variable expression of Parkinson's disease
|Neurology|1990|1.3k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k